Wayne Ray Archives
Dec. 12, 2018—Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry. Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.
Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk
Dec. 4, 2018—A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.
Oct. 13, 2016—A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks.
Jun. 14, 2016—Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
May. 26, 2015—The 2015 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during the May 19 Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research.
Jan. 20, 2015—Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release).
Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
Jun. 2, 2011—After a storied history of achievement in the areas of teaching, research and advocacy in the fields of prevention and public health, Vanderbilt’s Department of Preventive Medicine is expanding and will be re-named.